JAK2 and myeloproliferative neoplasm: Despite the wide availability of NGS-based targeted gene sequencing, point mutation tests for JAK2 V617F and single gene tests for CALR exon 9 indels are still routinely performed in many clinical laboratories owing to their cost-effectiveness and high diagnostic yield, particularly for the initial diagnosis of MPN.